| 1995 | Promotion zum Doktor der Naturwissenschaften (Medizinische Genetik) |
| 1990-1995 | Wissenschaftliche Mitarbeiterin, Boehringer Ingelheim Austria GmbH |
| 1995-1997 | Wissenschaftliche Mitarbeiterin, Universität Wien (Postdoc) |
| 1998-1999 | Produktmanagerin bei Margaritella-Biotrade GmbH |
| 1999-2005 | Leiterin von Life Science Austria bei der Innovationsagentur GmbH (seit 2003 aws) |
| 2000-2010 | Investmentmanagerin der UniVenture Fonds |
| 2002-2005 | Geschäftsführerin, ARGE LISA Vienna Region |
| 2003-2010 | Leiterin des Bereichs Technologie & Innovation und Gesamtprokuristin (seit 2003) in der Austria Wirtschaftsservice GmbH (aws) |
| 2004-2006 | Geschäftsführerin der ARGE Impulsprogramm Creativwirtschaft |
| 2008-2010 | Stellvertretende Vorsitzende, Universitätsrat Veterinärmedizinische Universität Wien |
| 2009-2010 | Aufsichtsrätin Innovacell Biotechnologie AG |
| 2010-2016 | Rektorin, Veterinärmedizinische Universität Wien |
| seit 2010 | Aufsichtsrätin Vetwidi Forschungsholding GmbH |
| seit 2011 | Aufsichtsratsvorsitzende Kunsthalle Wien GmbH |
| seit 2016 | Bundesministerin für Bildung und Frauen |
| 1979 | Tel Aviv University School of Law, Tel Aviv, Israel, LL.B. |
| 1980 | University of Strasbourg, France, Diploma for French Cultural and Historical Studies |
| 1981 | INSEAD - Institut Europeen d'Administration aux Affaires, Fountainbleau, France, M.B.A. |
| 1982 | Mennen Medical Company Ltd., Tel Aviv, Israel, Marketing Manager |
| 1986-1989 | Weizmann Institute of Science, Rehovot, Israel. Managing Director, YEDA Research & Development Co. Ltd.. Led the technology transfer program at the Weizmann Institute of Science where he negotiated multiple joint venture and royalty deals which continue to pay dividends in the multi-million dollar range |
| 1989-1998 | Vice President for Industrial Liaison, New York University Medical Center. Established and led the office of Science and Technology Administration at NYU School of Medicine, with responsibility for sponsored programs, research administration, clinical trials and technology transfer |
| 1989-2001 | New York University, NY |
| 1994-1998 | Associate Dean, Science and Technology Administration, NYU Medical Center |
| 1999-2001 | Vice Provost, Vice Dean, Industrial Liaison and Research Administration, NYU School of Medicine Established and led the technology transfer program at New York University, NYU School of Medicine and its affiliated hospitals; established and led NYU School of Medicine s Clinical Trials Development program and guided NYU's participation in and served on the Board of the Biomedical Research Alliance of New York. |
| 2001-2005 | Tel Aviv University, Israel. Chief Executive Officer, Ramot and the Economic Corporation reorganized the technology licensing operation, Ramot, at Tel Aviv University. Hired new senior staff managing a total of 28 and recruited the board, made up predominately of industrialists and venture capitalists, to whom Ramot reports. Established and led the Economic Corporation at Tel Aviv University to oversee the revenue generation centers of the University including real estate and technology transfer and the newly formed functions of publishing and E-learning. |
| since 2005 | Harvard University, responsible for the development of translating new knowledge and innovations into practical advances beneficial to society through technology transfer based on discoveries made throughout Harvard University. |
| 1990-1992 | Teaching Assistant, University of Aalborg, Denmark |
| 1992-1993 | Project Co-ordinator, University of Strathclyde, Glasgow, United Kingdom |
| 1993-1996 | Marketing Manager, The British Council Scotland, Glasgow, United Kingdom |
| 1996-2001 | International Marketing Manager, Research and Enterprise, University of Glasgow, United Kingdom |
| 2002-2003 | Head of Section, Danish Ministry of Science, Technology and Innovation, Copenhagen, Denmark |
| since 2003 | Director of Technology Transfer, University of Copenhagen |
| 2007 | Vice-President, Association of European Science and Technology Transfer Professionals (ASTP) |
| 1959-1963 | Studies of physics at Johann Wolfgang Goethe-Universität University in Frankfurt am Main, Germany, intermediate diploma 1962 |
| 1963-1969 | Continues studies of physics at Darmstadt University of Technology, Germany, diploma 1966, doctor's degree 1969 |
| 1969-1972 | Postdoctoral Fellow of National Research Council of Canada at Carleton University in Ottawa, Canada |
| since 1972 | Research scientist at the Institute of Solid State Research at Forschungszentrum Jülich, Germany |
| 1984 | Habilitation at the University of Cologne, Germany, "Privatdozent" |
| 1984-1985 | Research stay at Argonne National Laboratory, Illinois, USA |
| 1986 | Activities in the field of antiferromagnetic coupling in Fe/Cr/Fe layers |
| 1988 | Work on the GMR effect in Jülich, Germany |
| 1992 | Appointment as adjunct professor at the University of Cologne, Germany |
| 1998 | Six-month research stay at the University of Sendai and at Tsukuba Research Centre, Japan |
| 2004 | After 32 years at Jülich, Germany, Peter Grünberg retires, but continues working |
| 2007 | Helmholtz Professorship, Forschungszentrum Jülich, Germany |
| | *1938 - Buenos Aires, Argentina, Immigrated to Israel 1949 |
| 1964 | M.Sc. Polymer Chemistry, Hebrew University, Jerusalem |
| 1968 | Ph.D. Biochemistry of Bacterial Cell Walls, Weizmann Institute of Science, Rehovot, Israel |
| 1968-1970 | Post Doctorate, Tufts University Medical School, Boston, USA |
| since 1970 | Faculty Member, Department of Biological Chemistry, Weizmann Institute of Science |
| 1973 | Visiting Scientist, Max-Planck-Institute, Tuebingen |
| 1976 | Associate Professor with tenure |
| 1976-1977 | University of California, Berkeley |
| 1984 | Harvard University, Cambridge, MA |
| Full Professor, Weizmann Institute |
| 1985 | Besen-Brender Chair of Microbiology and Parasitology, Department of Biological Chemistry, Weizmann Institute of Science |
| 1991-1992 | Fogarty Scholar, National Institutes of Health, Bethesda, MD |
| 1987-1998 | Chairman of the Board of Directors, Yeda Research and Development Co. Ltd. |
| 1989-1992 | Member Board of Directors, News Datacom Corp., Jerusalem, Israel |
| 1991-1994 | Member Board of Directors, Weizmann Technological Incubator Company |
| 1993-1998 | Vice President for Technology Transfer, Weizmann Institute of Science |
| 1995-1998 | Member of Board of Directors, XTL Biotechnology, Rehovot, Israel |
| 1996-1998 | Member of Board of Directors of Portman Pharmaceuticals, Rehovot, Israel |
| 1999-2004 | Dean, Faculty of Biochemistry, Weizmann Institute of Science |
| 1999-2001 | President, Israel Society for Microbiology |
| 2004-2012 | President of Scientific Council, Conseil I.Pasteur-Weizmann I. |
| since 2010 | Member of Executive Board of Directors, Weizmann Institute of Science |
| 1994-1999 | TU Wien Wirtschaftsingenieurwesen, Dipl.-Ing. Industrie-Finanzierung Industrielle Betriebswirtschaftslehre Material Science |
| 1999-2001 | Studium TU Wien Wirtschaftsingenieurwesen, Dr. Dissertation: Unternehmensgründungen durch Venture Capital |
| 2001-2002 | Berater, Boston Consulting Group |
| 2002-2005 | Stv. Geschäftsführer, Wiener Wissenschafts- und Technologiefonds |
| 2005-2007 | Unternehmersgründer, Murauer & Partner |
| 2007-2012 | Managing Director, Institute of Science and Technology Austria (I.S.T. Austria) |
